Dosage & Administration Efficacy safety testing Drug label Prior authorization Financial assistance

Bavencio

(avelumab)

10 ML avelumab 20 MG/ML Injection [Bavencio]

NO BLACK BOX WARNING

Dosage & administration

* Premedicate for the first 4 infusions and subsequently as needed.
* Merkel Cell Carcinoma: 800 mg every 2 weeks.
* Urothelial Carcinoma; 800 mg every 2 weeks.
* Renal Cell Carcinoma: 800 mg every 2 weeks in combination with axitinib 5 mg orally twice daily.

Administer BAVENCIO as an intravenous infusion over 60 minutes.

eficacy, safety & testing

Bavencio clinical details

Mechanism of Action (MOA)

Clinical Trials: Locally Advanced or Metastatic UC

Efficacy: Locally Advanced or Metastatic UC

Safety Profile: Locally Advanced or Metastatic UC

Dosing & Administration: Locally Advanced or Metastatic UC

Clinical Trials: Metastatic MCC

Efficacy: Metastatic MCC

Safety Profile: Metastatic MCC

Dosing & Administration: Metastatic MCC

drug label

Bavencio prescribing information

Need to report a Bavencio issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Bavencio Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

CoverOne Enrollment Form

CoverOne Enrollment Form - Spanish

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Bavencio Financial assistance options

Co-pay savings program

commercial only

CoverOne Enrollment Form

CoverOne Enrollment Form - Spanish

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

CoverOne Enrollment Form

CoverOne Enrollment Form - Spanish

Patient Assistance Program

Enroll in Patient Savings Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Bavencio Patient education

Getting started on Bavencio

NOT PROVIDED BY BRANDInstructions For Use: Metastatic MCC

NOT PROVIDED BY BRANDInstructions For Use: Locally Advanced or Metastatic UC